HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter Mutch Selected Research

N- cyclohexyl- N3- (2- (3- fluorophenyl)ethyl)- N- (2- ((2- (4- hydroxy- 2- oxo- 2,3- dihydro- 1,3- benzothiazol- 7- yl)ethyl)amino)ethyl)- beta- alaninamide

3/2013Micronucleus induction in the bone marrow of rats by pharmacological mechanisms. II: long-acting beta-2 agonism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter Mutch Research Topics

Disease

1Hepatolenticular Degeneration (Wilson's Disease)
06/2018
1Respiratory Tract Diseases (Respiratory Tract Disease)
03/2013

Drug/Important Bio-Agent (IBA)

1Trientine (Trien)FDA Link
06/2018
1N- cyclohexyl- N3- (2- (3- fluorophenyl)ethyl)- N- (2- ((2- (4- hydroxy- 2- oxo- 2,3- dihydro- 1,3- benzothiazol- 7- yl)ethyl)amino)ethyl)- beta- alaninamideIBA
03/2013